Frontiers in Cellular and Infection Microbiology (May 2023)
The value of biofilm testing to guide antimicrobial stewardship in chronic respiratory diseases
- Laia Fernández-Barat,
- Laia Fernández-Barat,
- Nil Vázquez Burgos,
- Nil Vázquez Burgos,
- Victoria Alcaraz,
- Victoria Alcaraz,
- Leticia Bueno-Freire,
- Leticia Bueno-Freire,
- Ruben López-Aladid,
- Ruben López-Aladid,
- Roberto Cabrera,
- Roberto Cabrera,
- Albert Gabarrús,
- Albert Gabarrús,
- Andrea Palomeque,
- Andrea Palomeque,
- Patricia Oscanoa,
- Patricia Oscanoa,
- Adrian Ceccato,
- Adrian Ceccato,
- Ana Motos,
- Ana Motos,
- Rosanel Amaro,
- Rosanel Amaro,
- Thierry Bernardi,
- Thierry Bernardi,
- Christian Provot,
- Christian Provot,
- Alba Soler-Comas,
- Alba Soler-Comas,
- Laura Muñoz,
- Jordi Vila,
- Antoni Torres,
- Antoni Torres
Affiliations
- Laia Fernández-Barat
- Cellex Laboratory, CibeRes (CB06/06/0028)-Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), School of Medicine, University of Barcelona, Barcelona, Spain
- Laia Fernández-Barat
- Pneumology Service, Respiratory Institute, Hospital Clinic, Barcelona, Spain
- Nil Vázquez Burgos
- Cellex Laboratory, CibeRes (CB06/06/0028)-Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), School of Medicine, University of Barcelona, Barcelona, Spain
- Nil Vázquez Burgos
- Pneumology Service, Respiratory Institute, Hospital Clinic, Barcelona, Spain
- Victoria Alcaraz
- Cellex Laboratory, CibeRes (CB06/06/0028)-Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), School of Medicine, University of Barcelona, Barcelona, Spain
- Victoria Alcaraz
- Pneumology Service, Respiratory Institute, Hospital Clinic, Barcelona, Spain
- Leticia Bueno-Freire
- Cellex Laboratory, CibeRes (CB06/06/0028)-Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), School of Medicine, University of Barcelona, Barcelona, Spain
- Leticia Bueno-Freire
- Pneumology Service, Respiratory Institute, Hospital Clinic, Barcelona, Spain
- Ruben López-Aladid
- Cellex Laboratory, CibeRes (CB06/06/0028)-Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), School of Medicine, University of Barcelona, Barcelona, Spain
- Ruben López-Aladid
- Pneumology Service, Respiratory Institute, Hospital Clinic, Barcelona, Spain
- Roberto Cabrera
- Cellex Laboratory, CibeRes (CB06/06/0028)-Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), School of Medicine, University of Barcelona, Barcelona, Spain
- Roberto Cabrera
- Pneumology Service, Respiratory Institute, Hospital Clinic, Barcelona, Spain
- Albert Gabarrús
- Cellex Laboratory, CibeRes (CB06/06/0028)-Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), School of Medicine, University of Barcelona, Barcelona, Spain
- Albert Gabarrús
- Pneumology Service, Respiratory Institute, Hospital Clinic, Barcelona, Spain
- Andrea Palomeque
- Cellex Laboratory, CibeRes (CB06/06/0028)-Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), School of Medicine, University of Barcelona, Barcelona, Spain
- Andrea Palomeque
- Pneumology Service, Respiratory Institute, Hospital Clinic, Barcelona, Spain
- Patricia Oscanoa
- Cellex Laboratory, CibeRes (CB06/06/0028)-Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), School of Medicine, University of Barcelona, Barcelona, Spain
- Patricia Oscanoa
- Pneumology Service, Respiratory Institute, Hospital Clinic, Barcelona, Spain
- Adrian Ceccato
- Cellex Laboratory, CibeRes (CB06/06/0028)-Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), School of Medicine, University of Barcelona, Barcelona, Spain
- Adrian Ceccato
- Pneumology Service, Respiratory Institute, Hospital Clinic, Barcelona, Spain
- Ana Motos
- Cellex Laboratory, CibeRes (CB06/06/0028)-Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), School of Medicine, University of Barcelona, Barcelona, Spain
- Ana Motos
- Pneumology Service, Respiratory Institute, Hospital Clinic, Barcelona, Spain
- Rosanel Amaro
- Cellex Laboratory, CibeRes (CB06/06/0028)-Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), School of Medicine, University of Barcelona, Barcelona, Spain
- Rosanel Amaro
- Pneumology Service, Respiratory Institute, Hospital Clinic, Barcelona, Spain
- Thierry Bernardi
- BioFilm Pharma SAS, Lyon, France
- Thierry Bernardi
- BioFilm Control SAS, Saint Beauzire, France
- Christian Provot
- BioFilm Pharma SAS, Lyon, France
- Christian Provot
- BioFilm Control SAS, Saint Beauzire, France
- Alba Soler-Comas
- Cellex Laboratory, CibeRes (CB06/06/0028)-Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), School of Medicine, University of Barcelona, Barcelona, Spain
- Alba Soler-Comas
- Pneumology Service, Respiratory Institute, Hospital Clinic, Barcelona, Spain
- Laura Muñoz
- Microbiology Service, Hospital Clinic, Barcelona, Spain
- Jordi Vila
- Microbiology Service, Hospital Clinic, Barcelona, Spain
- Antoni Torres
- Cellex Laboratory, CibeRes (CB06/06/0028)-Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), School of Medicine, University of Barcelona, Barcelona, Spain
- Antoni Torres
- Pneumology Service, Respiratory Institute, Hospital Clinic, Barcelona, Spain
- DOI
- https://doi.org/10.3389/fcimb.2023.1142274
- Journal volume & issue
-
Vol. 13
Abstract
IntroductionBiofilm production is an important yet currently overlooked aspect of diagnostic microbiology that has implications for antimicrobial stewardship. In this study, we aimed to validate and identify additional applications of the BioFilm Ring Test® (BRT) for Pseudomonas aeruginosa (PA) isolates from patients with bronchiectasis (BE).Materials and methodsSputa were collected from BE patients who had at least one PA positive culture in the previous year. We processed the sputa to isolate both mucoid and non-mucoid PA, and determined their susceptibility pattern, mucA gene status, and presence of ciprofloxacin mutations in QRDR genes. The Biofilm production index (BPI) was obtained at 5 and 24 hours. Biofilms were imaged using Gram staining.ResultsWe collected 69 PA isolates, including 33 mucoid and 36 non-mucoid. A BPI value below 14.75 at 5 hours predicted the mucoid PA phenotype with 64% sensitivity and 72% specificity.ConclusionOverall, our findings suggest that the fitness-cost associated with the mucoid phenotype or ciprofloxacin resistance is shown through a time-dependent BPI profile. The BRT has the potential to reveal biofilm features with clinical implications.
Keywords